Vcanbio Cell & Gene Engineering Corp Ltd

SHG:600645 China Biotechnology
Market Cap
$1.89 Billion
CN¥13.85 Billion CNY
Market Cap Rank
#6107 Global
#888 in China
Share Price
CN¥29.59
Change (1 day)
-4.64%
52-Week Range
CN¥20.45 - CN¥31.37
All Time High
CN¥68.93
About

Vcanbio Cell & Gene Engineering Corp., Ltd, together with its subsidiaries, engages in the preparation and storage of cell detection tests in the People's Republic of China. It offers cell test preparation and storage services for umbilical cord blood hematopoietic stem cells, umbilical cord mesenchymal stem cells, placental pluripotent stem cells, immune cells, adipose stem cells, and dental ste… Read more

Vcanbio Cell & Gene Engineering Corp Ltd (600645) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of September 2025: 0.028x

Based on the latest financial reports, Vcanbio Cell & Gene Engineering Corp Ltd (600645) has a cash flow conversion efficiency ratio of 0.028x as of September 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥103.70 Million) by net assets (CN¥3.76 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Vcanbio Cell & Gene Engineering Corp Ltd - Cash Flow Conversion Efficiency Trend (1998–2024)

This chart illustrates how Vcanbio Cell & Gene Engineering Corp Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Vcanbio Cell & Gene Engineering Corp Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Vcanbio Cell & Gene Engineering Corp Ltd ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Vcanbio Cell & Gene Engineering Corp Ltd (1998–2024)

The table below shows the annual cash flow conversion efficiency of Vcanbio Cell & Gene Engineering Corp Ltd from 1998 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥3.66 Billion CN¥285.19 Million 0.078x -0.99%
2023-12-31 CN¥3.80 Billion CN¥299.02 Million 0.079x +9.82%
2022-12-31 CN¥3.65 Billion CN¥261.89 Million 0.072x -21.10%
2021-12-31 CN¥3.53 Billion CN¥320.96 Million 0.091x +30.22%
2020-12-31 CN¥3.50 Billion CN¥244.35 Million 0.070x -0.02%
2019-12-31 CN¥3.46 Billion CN¥241.49 Million 0.070x +60.09%
2018-12-31 CN¥2.98 Billion CN¥130.08 Million 0.044x +1.38%
2017-12-31 CN¥1.63 Billion CN¥70.27 Million 0.043x -47.58%
2016-12-31 CN¥1.75 Billion CN¥143.67 Million 0.082x +1587.16%
2015-12-31 CN¥1.68 Billion CN¥8.17 Million 0.005x -97.46%
2014-12-31 CN¥1.16 Billion CN¥221.45 Million 0.192x +14.17%
2013-12-31 CN¥660.07 Million CN¥110.72 Million 0.168x -32.93%
2012-12-31 CN¥281.54 Million CN¥70.41 Million 0.250x -39.12%
2011-12-31 CN¥268.85 Million CN¥110.44 Million 0.411x -42.99%
2010-12-31 CN¥244.13 Million CN¥175.93 Million 0.721x +38.01%
2009-12-31 CN¥239.23 Million CN¥124.92 Million 0.522x +10.06%
2008-12-31 CN¥256.31 Million CN¥121.60 Million 0.474x -21.23%
2007-12-31 CN¥185.42 Million CN¥111.68 Million 0.602x +45.63%
2006-12-31 CN¥184.04 Million CN¥76.12 Million 0.414x -19.44%
2005-12-31 CN¥164.95 Million CN¥84.69 Million 0.513x +175.49%
2004-12-31 CN¥309.95 Million CN¥57.76 Million 0.186x +62.98%
2003-12-31 CN¥365.02 Million CN¥41.74 Million 0.114x +377.40%
2002-12-31 CN¥357.83 Million CN¥-14.75 Million -0.041x +75.21%
2001-12-31 CN¥414.06 Million CN¥-68.84 Million -0.166x -327.53%
2000-12-31 CN¥433.95 Million CN¥31.71 Million 0.073x +632.86%
1999-12-31 CN¥414.12 Million CN¥4.13 Million 0.010x +112.92%
1998-12-31 CN¥416.47 Million CN¥-32.14 Million -0.077x --